LAURUSLABS — Laurus Labs Income Statement
0.000.00%
Last trade - 00:00
- IN₹235.50bn
- IN₹256.16bn
- IN₹60.41bn
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28,317 | 48,135 | 49,356 | 60,406 | 50,408 |
Cost of Revenue | |||||
Gross Profit | 12,509 | 24,584 | 24,828 | 28,757 | 26,084 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24,488 | 34,632 | 37,610 | 47,469 | 46,479 |
Operating Profit | 3,829 | 13,504 | 11,746 | 12,936 | 3,929 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,936 | 13,011 | 10,839 | 11,089 | 2,364 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,553 | 9,838 | 8,324 | 7,966 | 1,682 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,553 | 9,836 | 8,275 | 7,901 | 1,606 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,553 | 9,836 | 8,275 | 7,901 | 1,606 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.8 | 18.3 | 15.4 | 14.6 | 2.97 |
Dividends per Share |